Seattle Genetics, Inc.

NASDAQ: SGEN
$228.74
+$0.00 (+0.0%)
Closing Price on January 9, 2024

SGEN Articles

Tuesday's top analyst upgrades, downgrades and initiations included AbbVie, Apple, Arconic, CenturyLink, eHealth, Nvidia, Salesforce.com, Tesla and Teva Pharmaceutical.
Top analyst upgrades, downgrades and initiations for the first trading day of 2020 included Abbott Laboratories, Advanced Micro Devices, Analog Devices, Applied Materials, Ford, Illumina, Medtronic,...
Seattle Genetics shares jumped on Monday after the firm announced positive results from its midstage breast cancer trial.
Tuesday's top analyst upgrades, downgrades and initiations included Analog Devices, Blackstone, Bloom Energy, Cleveland-Cliffs, Ford, Micron Technology, PG&E, Snap and VMWare.
Immunomedics shares dropped sharply on Monday after the firm presented interim data from its midstage bladder cancer study at the European Society for Medical Oncology (ESMO) Annual Congress in...
Friday's top analyst upgrades, downgrades and initiations included Box, iRobot, Kimberly-Clark, Match, Oracle, Pinterest, Seattle Genetics andTexas Instruments.
24/7 Wall St. has looked over some of the biotech sector's laggards, and we have also looked over the top exchange-traded funds for a breakdown of what they own to show how much they are lagging...
The top analyst upgrades, downgrades and initiations seen on Thursday included Apple, Chipotle Mexican Grill, CEMEX, CVS, Eli Lilly, Hewlett Packard Enterprise, IBM, Incyte, MercadoLibre and U.S....
Seattle Genetics shares dipped on Monday following an update from the FDA on Adcetris for certain lymphomas.
The top analyst upgrades, downgrades and initiations seen on Wednesday included Analog Devices, Halliburton, Neovasc, Nike, NXP Semiconductors, PepsiCo, Skyworks Solutions and Whiting Petroleum.
Monday's s analysts upgrades and downgrades include Altria, Match Group, ConocoPhillips, Seattle Genetics, SunPower Corporation, and more.
The top analyst upgrades, downgrades and other research calls from Tuesday include AK Steel, BHP Billiton, Dominion Energy, JB Hunt, KLA-Tencor, Micron Technology, Nucor, Oracle, Roku and U.S. Steel.
Cascadian Therapeutics saw its shares absolutely skyrocket on Wednesday after it was announced that Seattle Genetics would be acquiring the company. This is far and away the top-performing stock in...
The top analyst upgrades, downgrades and other research calls from Friday include Baidu, Barclays, Celgene, HPE, Intel, Kimberly-Clark, Lululemon, PayPal and Stratasys.
Some of the top biotech stocks could become extremely volatile before and after earnings. These four that may be worth a look for aggressive investors.